Medication Adherence and the Role of Loved Ones: Considerations for Clinicians
Categories:
Department of Psychiatry ,
Best Practices in Schizophrenia Treatment (BeST) Center ,
Department of Psychiatry ,
Best Practices in Schizophrenia Treatment (BeST) Center ,
Cognitive Behavioral Therapy for Psychosis (CBT-p) ,
CBT-p and Family Systems Project ECHO ,
Department of Psychiatry ,
Best Practices in Schizophrenia Treatment (BeST) Center ,
Cognitive Behavioral Therapy for Psychosis (CBT-p) ,
Department of Psychiatry | Tags:
acceptance ,
adherence ,
anosognosia ,
anxiety ,
biopsychosocial model ,
clinical considerations ,
clinicians ,
communication ,
concerns ,
cost and benefits ,
diagnosis ,
diagnostic labels ,
education ,
evidence-based ,
expectations ,
families ,
family ,
family involvement ,
family members ,
family perspective ,
fear ,
frustration ,
hesitation ,
lack of insight ,
loved ones ,
medication ,
medication adherence ,
medication appointments ,
Mental Health ,
mental health diagnosis ,
mental illness ,
misinformation ,
misunderstanding ,
non-adherence ,
non-prescribers ,
normalizing ,
prescribers ,
psychoeducation ,
psychosis ,
psychotherapy ,
reservations ,
safety net ,
schizophrenia ,
stigma ,
techniques ,
therapists ,
track symptoms ,
tracking ,
treatment ,
treatment plan ,
treatment team ,
unawareness of illness ,
validating VIDEO
Danelle Hupp, Ph.D. describes to impact of loved ones on medication adherence. Potentially complex situtations related to family systems and medication adherence are discussed.
